πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 68 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12186363

Compositions and methods for dengue virus chimeric constructions in vaccines

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12152242

CRISPR therapy

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11986534

Treatment of anthrax with pegylated capsule-degrading enzyme

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11959096

Methods for selective inhibition of pluripotent stem cells

The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services NIH, Office of Technology Transfer Β· Granted Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11878064

Nanoparticle/peptide method of blocking potassium channels

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11865172

Materials and methods for respiratory disease control in canines

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11786601

Pegylated capsule-degrading enzyme for the treatment of anthrax

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11744834

Metal-porphyrin complexes for the inactivation of the biological activity of opioids

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11746335

Development of dengue virus vaccine components

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11739137

Single domain antibodies to SARS-CoV-2 nucleocapsid protein

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11617800

Nanoparticle-enhanced activity of a potassium channel-blocking peptide

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11542320

Nucleic acids encoding single domain antibodies to chikungunya virus

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11497803

Modulation of replicative fitness by deoptimization of synonymous codons

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11471528

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The Government of the United States of America as represented by the Secretary of the Department Β· Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11339387

Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 prec

The Government of the United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11332722

Development of dengue virus vaccine components

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11191824

Method of purifying virus-like-particles

The Government of the United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11160859

Materials and methods for respiratory disease control in canines

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11154608

Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominan

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11045558

RPGR gene therapy for retinitis pigmentosa

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11041008

Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11028152

Single domain antibodies to Chikungunya virus

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11008564

Processing engineered FMDV P1 polypeptide using an alternative TEV protease

The Government of the United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10934360

Human monoclonal antibodies against EPHA4 and their use

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted